The 8 analysts offering 12-month price forecasts for MacroGenics Inc have a median target of 39.00, with a high estimate of 50.00 and a low estimate of 23.00. The median estimate represents a +194.34% increase from the last price of 13.25.
The current consensus among 9 polled investment analysts is to Buy stock in MacroGenics Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.80
Reporting Date Mar 01
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.